PegAxokine: REGN began a placebo-controlled, dose-escalation Phase I trial in up to 25 to 30 obese volunteers. PegAxokine is formulated using PEG technology fro

Regeneron Pharmaceuticals Inc. (REGN), Tarrytown, N.Y.
Product:

Read the full 79 word article

How to gain access

Continue reading with a
two-week free trial.